awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q52686509-11E3EBFA-7DDF-4208-9167-42DF424D6DBE
Q52686509-11E3EBFA-7DDF-4208-9167-42DF424D6DBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52686509-11E3EBFA-7DDF-4208-9167-42DF424D6DBE
Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma.
P2860
Q52686509-11E3EBFA-7DDF-4208-9167-42DF424D6DBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q52686509-11E3EBFA-7DDF-4208-9167-42DF424D6DBE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c0375cf94e41f4da55011c13d6451974b9c4b2f7
P2860
Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.